Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
Jones ML, Holmes M
Record ID 32013000706
English
Authors' recommendations:
At the time of writing, the final appraisal determination document issued by NICE in April 2007 states that:
Alteplase is recommended for the treatment of acute ischaemic stroke when used by physicians trained and experienced in the management of acute stroke. It should only be administered in centres with facilities that enable it to be used in full accordance with its marketing authorisation.
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.journalslibrary.nihr.ac.uk/hta/hta13Suppl2-03/#/abstract
URL for additional information:
http://www.journalslibrary.nihr.ac.uk/hta/volume-13/suppl-2-article-3
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Cost-Benefit Analysis
- Female
- Male
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Sex Factors
- Time Factors
- Brain Ischemia
- Fibrinolytic Agents
- Stroke
- Tissue Plasminogen Activator
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.